These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30884127)

  • 21. The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables.
    Rowe CW; Dill T; Faulkner S; Gedye C; Paul JW; Tolosa JM; Jones M; King S; Smith R; Hondermarck H
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RAP1GAP Functions as a Tumor Suppressor Gene and Is Regulated by DNA Methylation in Differentiated Thyroid Cancer.
    Faam B; Ghaffari MA; Khorsandi L; Ghadiri AA; Totonchi M; Amouzegar A; Fanaei SA; Azizi F; Shahbazian HB; Hashemi Tabar M
    Cytogenet Genome Res; 2021; 161(5):227-235. PubMed ID: 34311462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.
    Arturi F; Russo D; Bidart JM; Scarpelli D; Schlumberger M; Filetti S
    Eur J Endocrinol; 2001 Aug; 145(2):129-35. PubMed ID: 11454507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M; Wu W; Gao M; Fei Z
    Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NONHSAT076754 aids ultrasonography in predicting lymph node metastasis and promotes migration and invasion of papillary thyroid cancer cells.
    Xia S; Wang C; Ni X; Ni Z; Dong Y; Zhan W
    Oncotarget; 2017 Jan; 8(2):2293-2306. PubMed ID: 27906682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated expression of nuclear protein kinase CK2α as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers.
    Guo M; Liu C; Qi FJ; Zhang XM; Ren LL; Liu YM; Meng ZC; Zhu ZT; Xiao JY
    Asian Pac J Cancer Prev; 2014; 15(17):7425-32. PubMed ID: 25227853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
    Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
    World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma].
    Qi ZJ; Liu LF; Cheng L; Han X; Wang T; Li F; Lu C; Zhang AB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):603-606. PubMed ID: 31327195
    [No Abstract]   [Full Text] [Related]  

  • 29. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of CCNE2 protein and mRNA expression in thyroid cancer tissues.
    Liu CZ; Guo WP; Peng JB; Chen G; Lin P; Huang XL; Liu XF; Yang H; He Y; Pang YY; Ma W
    Adv Med Sci; 2020 Sep; 65(2):442-456. PubMed ID: 33059229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns and predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma.
    Kim YS
    Otolaryngol Head Neck Surg; 2012 Jul; 147(1):15-9. PubMed ID: 22399280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
    Xu Y; Xu L; Wang J
    J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of motilin and its precursor mRNA in normal parenchyma, benign and malignant tumors of human thyroid].
    Xu L; Zhong F; Guo FF; Zhao WJ; Sun XR; Wei XF
    Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):243-9. PubMed ID: 18844033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
    Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
    J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.
    Yin DT; Xu J; Lei M; Li H; Wang Y; Liu Z; Zhou Y; Xing M
    Oncotarget; 2016 Feb; 7(5):5830-41. PubMed ID: 26716505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L; Shindo M; Schuff K; Corless C
    Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.
    Zhao C; Jiang W; Gao Y; Niu W; Zhang X; Xin L
    J Int Med Res; 2017 Jun; 45(3):1221-1230. PubMed ID: 28534700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma.
    Vergez S; Sarini J; Percodani J; Serrano E; Caron P
    Eur J Surg Oncol; 2010 Aug; 36(8):777-82. PubMed ID: 20584589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
    Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
    Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation.
    Cunha LL; Marcello MA; Morari EC; Nonogaki S; Conte FF; Gerhard R; Soares FA; Vassallo J; Ward LS
    Endocr Relat Cancer; 2013 Feb; 20(1):103-10. PubMed ID: 23193072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.